Cerebrolysin 60MG

What is Cerebrolysin 60MG?

Cerebrolysin is a neuropeptide formulation composed of low-molecular-weight peptides and amino acids derived from enzymatic hydrolysis of porcine (pig) brain proteins.
It is widely studied for its neuroprotective, neurotrophic, and cognitive-enhancement effects.
Researchers use Cerebrolysin in laboratory and preclinical models to simulate brain repair mechanisms in stroke, traumatic brain injury, neurodegeneration, and cognitive decline.
This product is for research use only and is not intended for human or veterinary therapeutic use.

Chemical Structure of Cerebrolysin 60MG

• Cerebrolysin is not a single peptide but a complex mixture of many low-molecular-weight peptides (some < 10 kDa) plus free amino acids.

• Among the bioactive fragments are peptides with similarities to growth factors such as NGF (nerve growth factor) and other neurotrophic molecules.

• Because of its heterogeneous composition, there is no single molecular formula or defined molecular weight for Cerebrolysin — its activity arises from the combined synergistic effect of the peptide fractions.

What Are the Effects of Cerebrolysin 60MG?

Based on preclinical and experimental research, Cerebrolysin has demonstrated:

• Neuroprotection & Anti-Excitotoxicity: In models of ischemic reperfusion injury, Cerebrolysin reduces neuronal cell death by modulating cell-death proteins (e.g., JNK, caspase-3) and attenuating excitotoxic signaling through NMDA receptor pathways.

• Activation of Antioxidant Pathways: In ischemia models, it activates the Keap1/Nrf2 antioxidant signaling pathway, reducing oxidative stress and promoting neuronal survival.

• Neurotrophic Support: Cerebrolysin stimulates the expression of neurotrophic factors (e.g., BDNF, NGF) that support neurogenesis, synaptic plasticity, and brain repair.

• Cognitive Function & Recovery: It has been studied for enhancing memory, learning, and recovery after neurological injury (e.g., stroke, TBI) due to its ability to promote synaptic repair and neuronal survival.

• Anti-inflammatory and Immunomodulatory Effects: Research suggests Cerebrolysin may reduce neuroinflammation and modulate immune signaling in the brain.

• Seizure Model Neuroprotection: In a pilocarpine-induced seizure study, Cerebrolysin was shown to reduce hippocampal neuronal death and increase BDNF expression.

Research-Use Only Disclaimer

This formulation of Cerebrolysin (60 mg) is for laboratory and scientific research purposes only.
It is not approved for human use in many jurisdictions, and its usage should be limited to controlled preclinical or in vitro experiments.